Ipsen Pharmaceuticals

Parachute over a desert
Biotech

BioNTech founders to pioneer new company—Chutes & Ladders

BioNTech founders will depart to pioneer new company. OSE makes interim CEO permanent. Ipsen adds former Alltrna CEO as North America leader.
A ballpoint pen rests on top of a stack of documents ready for signing

Ipsen's ADC push leads to $1B deal for preclinical Simcere drug

Dec 22, 2025 7:15am
saker falcon

Ipsen fails to land pivotal rare disease trial

Dec 19, 2025 3:37pm
Illustration connected puzzle pieces with the acronym MA

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am
liver disease fibrosis NASH NAFLD cancer cirrhosis liver

Zydus' phase 3 win tees up filing to challenge Gilead and Ipsen

Aug 29, 2025 10:59am
illustration of two arrows going in opposite directions

Ipsen hands back Sutro's ROR1 ADC at center of $875M deal

Aug 8, 2025 6:15am